0
Skip to Content
Aqualung Therapeutics, Corp
Home
Science
ALT-100
Pipeline
About US
Management
Scientific Advisory Board
Board of Directors
Resources
ROADMAP
News & Press Releases
Publications
Contact Us
Aqualung Therapeutics, Corp
Home
Science
ALT-100
Pipeline
About US
Management
Scientific Advisory Board
Board of Directors
Resources
ROADMAP
News & Press Releases
Publications
Contact Us
Home
Folder: Science
Back
ALT-100
Pipeline
Folder: About US
Back
Management
Scientific Advisory Board
Board of Directors
Folder: Resources
Back
ROADMAP
News & Press Releases
Publications
Contact Us
Healing lungs, improving data, oncology research and more
KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20 KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20

Healing lungs, improving data, oncology research and more

Healing lungs, improving data, oncology research and more Jeff Gardner, Inside Tucson Business Jun 19, 2020 With a major research university

Read More
El Covid-19: un futuro impredecible para la humanidad
KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20 KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20

El Covid-19: un futuro impredecible para la humanidad

El Covid-19: un futuro impredecible para la humanidad Siete años atrás, el Dr. Joe G. N. “Skip” Garcia, MD, un

Read More
Radiation-induced lung injury: Is there finally an approved treatment on the way?
KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20 KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20

Radiation-induced lung injury: Is there finally an approved treatment on the way?

TUCSON, Ariz.—Aqualung Therapeutics, an early-stage biotech company developing immune-focused therapeutic antibodies for patients suffering from acute and chronic disorders characterized by systemic

Read More
Científicos trabajan en la lucha contra el COVID-19
KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20 KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20

Científicos trabajan en la lucha contra el COVID-19

Científicos trabajan en la lucha contra el COVID-19 PLAY VIDEO 06.20.2020

Read More
Aqualung Takes Genomic Approach to COVID-19’s Killer Lung Inflammation
KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20 KEY ACTIVITIES & PRESS Rebecca Nunn 7/21/20

Aqualung Takes Genomic Approach to COVID-19’s Killer Lung Inflammation

Targets Protein Linked To Acute Respiratory Distress Syndrome Aqualung Takes Genomic Approach to COVID-19’s Killer Lung Inflammation Andrew McConaghieandrew.mcconaghie@informa.com Executive Summary Acute

Read More
COVID Patients in Intensive Care units – KGUN9 Interview
KEY ACTIVITIES & PRESS Rebecca Nunn 7/17/20 KEY ACTIVITIES & PRESS Rebecca Nunn 7/17/20

COVID Patients in Intensive Care units – KGUN9 Interview

Dr. Joe GN Garcia talks with local news station KGUN-9 about the uptick in deaths with COVID-19, primarily in patients transferred to ICU.

Read More
Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Against COVID-19
KEY ACTIVITIES & PRESS Rebecca Nunn 6/21/20 KEY ACTIVITIES & PRESS Rebecca Nunn 6/21/20

Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Against COVID-19

PLAY PRESS RELEASE 05.27.2020

Read More
KEY ACTIVITIES & PRESS Rebecca Nunn 5/17/20 KEY ACTIVITIES & PRESS Rebecca Nunn 5/17/20

AquaLung Therapeutics Corp. Receives NIH Approval to Advance to IND-Enabling Studies Via the STTR Fastrack Phase II Award for Development of A Novel Anti-Inflammatory Therapeutic Antibody for ARDS…

READ PRESS RELEASE 5.20.20

Read More
Fight Against COVID 19 May Yield Solutions to ARDS
KEY ACTIVITIES & PRESS Rebecca Nunn 4/7/20 KEY ACTIVITIES & PRESS Rebecca Nunn 4/7/20

Fight Against COVID 19 May Yield Solutions to ARDS

READ PRESS RELEASE 4.7.20

Read More

OFFICE

Mailing Address
6080 N Pinchot Rd
Tucson, Az 85750

450 Ocean Drive, 1205
Juno Beach, FL 33408

CONTACT

Email: info@aqualungtherapeutics.com
Tel: 312-618-7337 or
919-410-0504